MetaVia
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MetaVia and other ETFs, options, and stocks.About MTVA
MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.
MTVA Key Statistics
Stock Snapshot
As of today, MetaVia(MTVA) shares are valued at $1.58. The company's market cap stands at 5.37M, with a P/E ratio of -0.10.
On 2026-03-04, MetaVia(MTVA) stock traded between a low of $1.50 and a high of $1.68. Shares are currently priced at $1.58, which is +5.3% above the low and -5.9% below the high.
The MetaVia(MTVA)'s current trading volume is 130.68K, compared to an average daily volume of 132.67K.
During the past year, MetaVia(MTVA) stock moved between $1.43 at its lowest and $23.10 at its peak.
During the past year, MetaVia(MTVA) stock moved between $1.43 at its lowest and $23.10 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.